Elizabeth Ralevski | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2360

Journal of Addiction Research & Therapy received 2360 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Elizabeth Ralevski

Department of Veterans Affairs, Alcohol Research Center, VA Connecticut Healthcare System, Connecticut, USA


Dr. Ralevski received her Ph.D. in Psychology in 2000 from York University in Toronto, Canada. She completed her post-doctoral fellowship at Harvard Medical School and joined the faculty at Yale University in 2001. She is currently an Assistant Professor of Psychiatry at Yale University School of Medicine and the Project Director for the Substance Abuse Treatment Program at VA Connecticut Healthcare System, West Haven Campus. Her research interests include the search for novel treatments for individuals with dual diagnosis of alcoholism and other psychiatric conditions, including depression, post-traumatic stress disorder (PTSD), schizophrenia, or borderline personality disorder. Her current research in this area involves examining: (a) mecamylamine for the treatment of individuals with alcohol dependence; (b) prazosin for the treatment of individuals with alcohol dependence and PTSD; and (c) modified version of cognitive processing therapy (E-CPT-C) to treat individuals with alcohol dependence and PTSD. Dr. Ralevski’s other research examines factors, such as stress, that may lead to the development and maintenance of alcoholism and other mental disorders. -
Research Interest
Dr. Ralevski is currently conducting a study that examines stress as a marker for relapse to alcohol in individuals with alcohol dependence and PTSD. She is also interested in the combined effects of alcohol and nicotine on cognition and behavior in smokers and non-smokers. In a current project, Dr. Ralevski will be examining the combined effects of these substances in smokers.